Women’s Health

The Root Causes of the Innovation Gap in Women’s Health

Dr. Dina Radenkovic, CEO of Gameto, discusses the company's pioneering use of induced pluripotent stem cell (iPSC) technology in fertility treatments, particularly addressing ovarian aging. Its lead product, Fertilo, is an iPSC-derived ovarian support cell line in phase III clinical trials in the US with FDA clearance, and commercial availability in markets like Australia and Latin America. The company faces challenges including the scarcity of human eggs and regulatory hurdles. Radenkovic also highlights the need for better models to study female-specific conditions and the importance of political advocacy and funding to drive innovation in women's health.
Read More

Australian Government Subsidizes Key Medications To Boost Women’s Health

The Australian government is set to make significant changes to women’s health care by adding popular medications to the Pharmaceutical Benefits Scheme (PBS). Starting May 1, 2025, three major medications will be subsidized, providing financial relief to thousands of women facing high costs for contraceptive, endometriosis, and IVF treatments.
Read More

AAMC Statement on Drastic Cuts to NIH-Funded Research

“The administration’s announcement that it plans to cut federal support of biomedical research by drastically reducing reimbursement of research costs related to peer-reviewed grants from the NIH will diminish the nation’s research capacity, slowing scientific progress and depriving patients, families, and communities across the country of new treatments, diagnostics, and preventative interventions.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.